Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment

Chest

Volumn 109, Issue 6, 1996, Pages 1562-1565

  Vidal, Rafael ^a   Martín Casabona, Nuria ^a   Juan, Arturo ^a   Falgueras, Teresa ^a   Miravitlles, Marc ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

antituberculous treatment; nontuberculous mycobacteria; pulmonary tuberculosis; relapse; treatment failure; unviable bacilli

Indexed keywords

CYCLOSERINE; ETHAMBUTOL; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPUTUM ANALYSIS; TREATMENT OUTCOME;

EID: 0029941974     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.6.1562     Document Type: Article

References (16)

1. Vidal R, de Gracia J, Ruiz J, et al. Estudio controlado de 637 pacientes con tuberculosis: diagnóstico y resultados terapéuticos con esquemas de 6 y 9 meses. Med Clin (Barc) 1986; 87:368-70
2. Ormerod LP, McCarthy OR, Rudd RM, et al. Short course chemotherapy for pulmonary tuberculosis. Respir Med 1991; 85: 291-94
3. British Thoracic Society. A controlled trial of 6-months chemotherapy in pulmonary tuberculosis: final report: results during the 36 months after the end of chemotherapy and beyond. Br J Dis Chest 1984; 78:330-36
4. Warring FC, Sutramongkole U. Nonculturable acid-fast forms in the sputum of patients with tuberculosis and chronic pulmonary disease. Am Rev Respir Dis 1979; 102:714-24
5. Levy H, Feldman CH, Sacho H, et al. A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest 1989; 95:1193-97
6. Kim TC, Blackman RS, Heatwole KM, et al. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Am Rev Respir Dis 1984; 129:264-68
7. Comité de expertos en tuberculosis. Consenso nacional para el control de la tuberculosis en España. Med Clin (Barc) 1992; 98:24-31
8. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134:355-63
9. Ormerod LP, Joint Tuberculosis Committee. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1990; 45:403-08
10. Vestal AL. Procedures for isolation and identification of mycobacteria. Atlanta: US Dept of Health Education and Welfare. Centers for Disease Control, publication N79-8230.12, 1978
11. American Thoracic Society. Diagnosis and treatment of diseases caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990; 142:940-53
12. Martín N, González T, Fernández F. Micobacteriosis: presentación de 38 casos. Med Clin (Barc) 1985; 84:651-54
13. Weir JA, Storey PB, Walrath MS, et al. The incidence of smear-positive culturally negative sputum in patients with pulmonary tuberculosis. Transactions of the 14th Conference on Chemotherapy Against Tuberculosis. VA-Armed Forces. Washington. DC: VA Dept of Medicine and Surgery Central Office, 1955: 255-58
14. de Gracia J, Curull Y, Vidal R, et al. Diagnostic value of bronchoalveolar lavage in suspected pulmonary tuberculosis. Chest 1988; 93:329-32
15. Elcuaz Romano R, Martín Casabona N, González Fuente T, et al. Infecciones por micobacterias: rendimiento de la baciloscopia en differentes muestras clínicas (1975-1988). Med Clin (Barc) 1991; 97:211-14
16. Davidson PT, M. avium complex, M. Kansasii, M. fortuitum and other mycobacteria causing human disease. In: Reichman LB, and Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker, 1993; 505-30